Aurora Investment Counsel’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
11,027
+507
| +5% | +$63.7K | 0.73% | 74 |
|
|
2025
Q1 | $1.16M | Buy |
10,520
+138
| +1% | +$15.3K | 0.65% | 79 |
|
|
2024
Q4 | $1.42M | Sell |
10,382
-63
| -0.6% | -$8.6K | 0.78% | 67 |
|
|
2024
Q3 | $1.2M | Buy |
10,445
+8
| +0.1% | +$922 | 0.65% | 82 |
|
|
2024
Q2 | $1.44M | Sell |
10,437
-118
| -1% | -$16.2K | 0.84% | 68 |
|
|
2024
Q1 | $1.46M | Sell |
10,555
-3,171
| -23% | -$437K | 0.83% | 68 |
|
|
2023
Q4 | $1.45M | Buy |
13,726
+342
| +3% | +$36.2K | 0.94% | 53 |
|
|
2023
Q3 | $1.51M | Sell |
13,384
-124
| -0.9% | -$14K | 1% | 39 |
|
|
2023
Q2 | $1.27M | Sell |
13,508
-151
| -1% | -$14.2K | 0.82% | 64 |
|
|
2023
Q1 | $1.38M | Buy |
+13,659
| New | +$1.38M | 0.9% | 56 |
|